Development of quality control methods of promising anticonvulsant
Journal Title: ScienceRise: Pharmaceutical Science - Year 2018, Vol 0, Issue 6
Abstract
<p>In the previous studies, NUPh scientists proved that the search of potential anticonvulsants among derivatives of 1,3,4-thiadiazole is very perspective [1-3]. At the medicinal chemistry department of NUPh N-(5-ethyl-[1,3,4]-thiadiazole-2-yl)-2-nitrobenzamide was synthesized. This substance demonstrated high anticonvulsive activity on pentylentetrazole model of seizure compared to classic drug «Depakin». The substance is patented and proposed for further preclinical studies. One of the most important stages in the introduction of a new medicinal product or substance into medical practice is the development of quality control techniques.</p><p>The aim. The aim of this work was to develop methods of identification, determination of impurities and quantitative determination of N- (5-ethyl- [1,3,4] -thiadiazole-2-yl)-2-nitrobenzamide for further application in standardization of the substance.</p><p>Methods. Chromatographically pure sample of N- (5-ethyl- [1,3,4] -thiadiazole-2-yl) -2-nitrobenzamide, methods of IR, UV and 1H NMR spectroscopy.</p><p>Results. The physical-chemical properties and spectral characteristics of N-(5-ethyl-[1,3,4]-thiadiazole-2-yl)-2-nitrobenzamide were studied, and chemical identification methods were proposed. The optimal conditions for the determination of the impurities by the method of thin-layer chromatography using the method of internal normalization are selected. The assay for N- (5-ethyl- [1,3,4] -thiadiazol-2-yl) -2-nitrobenzamide was carried out by absorption spectrophotometry in the alcohol solution at the wavelength of 282 nm with the absorption index 631. For application of methods such validation characteristics as robustness, linearity, correctness, stability of analytical solutions, precision, convergence, reproducibility, calculation of uncertainty of samples preparation were studied.</p><p>Conclusions. The methods of identification of N- (5-ethyl- [1,3,4] -thiadiazol-2-yl) -2-nitrobenzamide with the use of chemical reactions and spectral methods of analysis - IR and UV and 1H NMR spectroscopy have been developed. To determine the concomitant impurities in the substance, the TLC method is recommended. Specific and nonspecific impurities were determined. The method of quantitative determination of substance by absorption spectrophotometry method in the ultraviolet region by the method of specific absorption index have been developed</p>
Authors and Affiliations
Igor Sych, Natalia Bevz, Irina Sych, Maryna Rakhimova, Vitaliy Yaremenko, Lina Perekhoda
Keywords
Related Articles
- EP ID EP526862
- DOI 10.15587/2519-4852.2018.152837
- Views 165
- Downloads 0
Analysis of factors that influence on organization of educational and production practice in preparation of pharmacy specialists
<p><strong>The aim: </strong>The aim of the study is to group and analyze external and internal factors that influence on the process of organization of educational and production practices as a component of professional...
Нормативне обґрунтування виробництва, контролю якості та безпечності лікарських засобів на основі наноматеріалів
<p><strong>Мета.</strong> Аналіз українських нормативних документів щодо лікарських засобів на основі наноматеріалів та вивчення міжнародного досвіду з питань їх розробки, контролю якості та безпечності.</p><p><strong>Ме...
Synthesis of potential antiexudative preparations for 2-((4-amino-5-(furan-2-il)-1,2,4-triazole-(4H)-3-yl)-sulfanyl)-N-acetamide series
<p><strong>Aim.</strong> Conduct the purposeful synthesis of new potential biologically active substances of derivatives of 2 - ((4-amino-5- (furan-2-yl) -1,2,4-triazol (4H) -3-yl) -sulfanyl) -N-acetamides and evaluate t...
Development of method of quantitative determination of cardiazol substance with using highly efficient liquid chromatography
<p><strong>The aim.</strong> Development of methods of quantitative determination of Cardiazol substance using high-performance liquid chromatography.</p><p><strong>Materials and methods. </strong>The method of high-perf...
Evaluation of opportunities for the use of modern methods for correction and prevention of risks in the quality control of clinical trials
To organize and conduct a clinical trial (СT) at a high level, it is necessary to continuously monitor its quality, as the occurrence of non-conformances can threaten health and safety of the trial subjects, as well as l...